BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10516687)

  • 1. An unusual case of intrapulmonary granulocytic sarcoma presenting as interstitial pneumonitis following allogeneic bone marrow transplantation for acute myeloid leukaemia and responding to donor lymphocyte infusion.
    Kottaridis PD; Ketley N; Peggs K; Chakraverty R; Ralleigh G; Shaw P; Pezzella F; Goldstone AH; Devereux S; Mackinnon S
    Bone Marrow Transplant; 1999 Oct; 24(7):807-9. PubMed ID: 10516687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease: a case report.
    Cesaro S; Messina C; Rosolen A; Putti MC; Sainati L; Destro R; Gazzola MV; Varotto S; De Silvestro G; Scarzello G; Spinelli M; Pillon M; Zanesco L
    Bone Marrow Transplant; 1999 Mar; 23(6):625-8. PubMed ID: 10217195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
    Schmid C; Labopin M; Nagler A; Bornhäuser M; Finke J; Fassas A; Volin L; Gürman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
    J Clin Oncol; 2007 Nov; 25(31):4938-45. PubMed ID: 17909197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated extramedullary relapse in the pleural fluid of a patient with acute myeloid leukemia following allogeneic BMT.
    Park J; Park SY; Cho HI; Lee D
    Bone Marrow Transplant; 2002 Jul; 30(1):57-9. PubMed ID: 12105780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
    Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
    Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe eosinophilia as a manifestation of acute graft-versus-host disease.
    Paralkar VR; Goradia A; Luger SM; Loren AW
    Oncology; 2008; 75(3-4):134-6. PubMed ID: 18791329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation.
    Imoto S; Murayama T; Gomyo H; Mizuno I; Sugimoto T; Nakagawa T; Koizumi T
    Bone Marrow Transplant; 2000 Oct; 26(7):809-10. PubMed ID: 11042667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of sarcoidosis after allogeneic bone marrow transplantation with donor lymphocyte infusions.
    Tauro S; Mahendra P
    Bone Marrow Transplant; 2001 Apr; 27(7):757-9. PubMed ID: 11360118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
    Yago K; Itoh M; Shimada H
    Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome.
    Depil S; Deconinck E; Milpied N; Sutton L; Witz F; Jouet JP; Damaj G; Yakoub-Agha I;
    Bone Marrow Transplant; 2004 Mar; 33(5):531-4. PubMed ID: 14716345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion.
    Orsini E; Alyea EP; Schlossman R; Canning C; Soiffer RJ; Chillemi A; Neuberg D; Anderson KC; Ritz J
    Bone Marrow Transplant; 2000 Mar; 25(6):623-32. PubMed ID: 10734296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Mar; 42(3):204-8. PubMed ID: 11345783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.
    Lee CK; deMagalhaes-Silverman M; Hohl RJ; Hayashi M; Buatti J; Wen BC; Schlueter A; Strauss RG; Gingrich RD
    Bone Marrow Transplant; 2003 Jan; 31(2):121-8. PubMed ID: 12621494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
    Mandigers CM; Verdonck LF; Meijerink JP; Dekker AW; Schattenberg AV; Raemaekers JM
    Bone Marrow Transplant; 2003 Dec; 32(12):1159-63. PubMed ID: 14647270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
    Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.
    Cwynarski K; Goulding R; Pocock C; Dazzi F; Craddock C; Kaeda J; Olavarria E; Kanfer E; Apperley J; Lawler M; Goldman JM
    Bone Marrow Transplant; 2001 Sep; 28(6):581-6. PubMed ID: 11607771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy.
    Wang JY; Chang YL; Lee LN; Chen JH; Tang JL; Yang PC; Lee YC
    Ann Thorac Surg; 2004 Jul; 78(1):267-72. PubMed ID: 15223441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.